Ocular Therapeutix (OCUL) Change in Inventory (2014 - 2026)
Ocular Therapeutix's quarterly Change in Inventory came in at $173000.0 in Q1 2026, down 24.45% year-on-year from $229000.0 in Q1 2025, and up 127.63% quarter-over-quarter from $76000.0 in Q4 2025.
Ocular Therapeutix has reported Change in Inventory for 13 years, with the latest figure at $173000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Inventory fell 24.45% year-over-year to $173000.0; the trailing twelve-month figure through Mar 2026 stood at $468000.0 (down 32.66% YoY), and the FY2025 full-year result was $524000.0, down 28.71% from the prior year.
- Change in Inventory for Q1 2026 stood at $173000.0, up from $76000.0 in the prior quarter.
- The five-year high for Change in Inventory was $635000.0 in Q4 2024, with the low at -$230000.0 in Q2 2025.
- Average Change in Inventory over 5 years is $146294.1, with a median of $108000.0 recorded in 2022.
- Year-over-year, Change in Inventory surged 1432.14% in 2022 and plunged 751.85% in 2025.
- Tracing OCUL's Change in Inventory over 5 years: stood at $429000.0 in 2022, then sank by 88.81% to $48000.0 in 2023, then surged by 1222.92% to $635000.0 in 2024, then tumbled by 88.03% to $76000.0 in 2025, then soared by 127.63% to $173000.0 in 2026.
- The last three Change in Inventory figures came in at $173000.0 (Q1 2026), $76000.0 (Q4 2025), and $449000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 665.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 97.70 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -26.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.32 Mn |
| 10 | Ocular Therapeutix | 1.99 Bn | 1.99 Bn | 9.46 Mn | 173,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 173,000.00 |
| Mar 31, 2026 | 173,000.00 |
| Dec 31, 2025 | 76,000.00 |
| Dec 31, 2025 | 76,000.00 |
| Sep 30, 2025 | 449,000.00 |
| Sep 30, 2025 | 449,000.00 |
| Jun 30, 2025 | -230,000.00 |
| Jun 30, 2025 | -230,000.00 |
| Mar 31, 2025 | 229,000.00 |
| Mar 31, 2025 | 229,000.00 |
| Dec 31, 2024 | 635,000.00 |
| Dec 31, 2024 | 635,000.00 |
| Sep 30, 2024 | -142,000.00 |
| Sep 30, 2024 | -142,000.00 |
| Jun 30, 2024 | -27,000.00 |
| Jun 30, 2024 | -27,000.00 |
| Mar 31, 2024 | 269,000.00 |
| Mar 31, 2024 | 269,000.00 |
| Dec 31, 2023 | 48,000.00 |
| Dec 31, 2023 | 48,000.00 |
| Sep 30, 2023 | 53,000.00 |
| Sep 30, 2023 | 53,000.00 |
| Jun 30, 2023 | -62,000.00 |
| Jun 30, 2023 | -62,000.00 |
| Mar 31, 2023 | 292,000.00 |
| Mar 31, 2023 | 292,000.00 |
| Dec 31, 2022 | 429,000.00 |
| Dec 31, 2022 | 429,000.00 |
| Sep 30, 2022 | 45,000.00 |
| Sep 30, 2022 | 45,000.00 |
| Jun 30, 2022 | 142,000.00 |
| Jun 30, 2022 | 142,000.00 |
| Mar 31, 2022 | 108,000.00 |
| Mar 31, 2022 | 108,000.00 |
| Dec 31, 2021 | 28,000.00 |
| Dec 31, 2021 | 28,000.00 |
| Sep 30, 2021 | 110,000.00 |
| Sep 30, 2021 | 110,000.00 |
| Jun 30, 2021 | -11,000.00 |
| Jun 30, 2021 | -11,000.00 |
| Mar 31, 2021 | -78,000.00 |
| Mar 31, 2021 | -78,000.00 |
| Dec 31, 2020 | 47,000.00 |
| Dec 31, 2020 | 47,000.00 |
| Sep 30, 2020 | 87,000.00 |
| Sep 30, 2020 | 87,000.00 |
| Jun 30, 2020 | -40,000.00 |
| Jun 30, 2020 | -40,000.00 |
| Mar 31, 2020 | 153,000.00 |
| Mar 31, 2020 | 153,000.00 |
| Dec 31, 2019 | 59,000.00 |
| Dec 31, 2019 | 59,000.00 |
| Sep 30, 2019 | 133,000.00 |
| Sep 30, 2019 | 133,000.00 |
| Jun 30, 2019 | 497,000.00 |
| Jun 30, 2019 | 497,000.00 |
| Mar 31, 2019 | 48,000.00 |
| Mar 31, 2019 | 48,000.00 |
| Dec 31, 2018 | 115,000.00 |
| Dec 31, 2018 | 115,000.00 |
| Sep 30, 2018 | -29,000.00 |
| Sep 30, 2018 | -29,000.00 |
| Jun 30, 2018 | -8,000.00 |
| Jun 30, 2018 | -8,000.00 |
| Mar 31, 2018 | 17,000.00 |
| Mar 31, 2018 | 17,000.00 |
| Dec 31, 2017 | -5,000.00 |
| Dec 31, 2017 | -5,000.00 |
| Sep 30, 2017 | 37,000.00 |
| Sep 30, 2017 | 37,000.00 |
| Jun 30, 2017 | -6,000.00 |
| Jun 30, 2017 | -6,000.00 |
| Mar 31, 2017 | -17,000.00 |
| Mar 31, 2017 | -17,000.00 |
| Dec 31, 2016 | -13,000.00 |
| Dec 31, 2016 | -13,000.00 |
| Sep 30, 2016 | -23,000.00 |
| Sep 30, 2016 | -23,000.00 |
| Jun 30, 2016 | 22,000.00 |
| Jun 30, 2016 | 22,000.00 |
| Mar 31, 2016 | -7,000.00 |
| Mar 31, 2016 | -7,000.00 |
| Dec 31, 2015 | -13,000.00 |
| Dec 31, 2015 | -13,000.00 |
| Sep 30, 2015 | 2,000.00 |
| Sep 30, 2015 | 2,000.00 |
| Jun 30, 2015 | -13,000.00 |
| Jun 30, 2015 | -13,000.00 |
| Mar 31, 2015 | 25,000.00 |
| Mar 31, 2015 | 25,000.00 |
| Dec 31, 2014 | 16,000.00 |
| Dec 31, 2014 | 16,000.00 |
| Sep 30, 2014 | 8,000.00 |
| Sep 30, 2014 | 8,000.00 |
| Jun 30, 2014 | 22,000.00 |
| Jun 30, 2014 | 22,000.00 |
| Mar 31, 2014 | 87,000.00 |
| Mar 31, 2014 | 87,000.00 |